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been recruited into the human mitochondrial
ribosome
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Bioinformatic analysis classifies the human protein en-
coded by immature colon carcinoma transcript-1 (ICT1) as
one of a family of four putative mitochondrial translation
release factors. However, this has not been supported by
any experimental evidence. As only a single member of
this family, mtRF1a, is required to terminate the synthesis
of all 13 mitochondrially encoded polypeptides, the true
physiological function of ICT1 was unclear. Here, we
report that ICT1 is an essential mitochondrial protein,
but unlike the other family members that are matrix-
soluble, ICT1 has become an integral component of the
human mitoribosome. Release-factor assays show that
although ICT1 has retained its ribosome-dependent PTH
activity, this is codon-independent; consistent with its
loss of both domains that promote codon recognition
in class-I release factors. Mutation of the GGQ domain
common to ribosome-dependent PTHs causes a loss of
activity in vitro and, crucially, a loss of cell viability,
in vivo. We suggest that ICT1 may be essential for hydro-
lysis of prematurely terminated peptidyl-tRNA moieties in
stalled mitoribosomes.
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Introduction
Human mitochondria are ubiquitous organelles that are es-
sential for cell viability. Among many crucial functions,
mitochondria couple the process of oxidative phosphoryla-
tion, where cellular respiration is harnessed to generate ATP.
This demanding mechanism requires the synthesis and import
of many nucleus-encoded proteins as well as the intramito-
chondrial production of 13 polypeptides that are encoded
by the mitochondrial genome, mtDNA. Consequently, correct
maintenance and expression of mtDNA is essential for cell
viability. Although we are gradually learning more about the
principal factors and mechanisms underlying the mainte-
nance and transcription of mtDNA, the process of mitochon-
drial translation has proven extremely difficult to be
characterised in detail. This is in part because isolated mito-
chondria lose their capacity to synthesise proteins after solu-
bilisation of the inner membrane, consistent with loss of
crucial membrane-associated factors. Furthermore, despite
impressive efforts to reconstitute in vitro mitochondrial trans-
lation systems (Yasukawa et al, 2001; Takemoto et al, 2009),
results have been limited. Invaluable contributions from the
laboratories of Spremulli, Watanabe and O’Brien have identi-
fied or characterised constituents of both the bovine small
28S (mt-SSU) (Suzuki et al, 2001) and large 39S (mt-LSU)
(Koc et al, 2001) mitoribosomal subunits and many proteins
involved in translational initiation and elongation (Spremulli
et al, 2004), but important factors remain to be unearthed.
To improve our understanding of this process, we have
started to identify other principal components in mitochon-
drial protein synthesis. We have focused our efforts on a
previous report where tagged mitochondrial ribosome recy-
cling factor (mtRRF) was shown to immunoprecipitate mitor-
ibosomes and associated proteins from mitochondrial lysates
(Rorbach et al, 2008). Proteomic analysis uncovered a large
number (73) of mitoribosomal proteins (MRPs). In addi-
tion, another 94 polypeptides were identified, a number of
which have been tentatively identified as nucleoid proteins.
Immature colon carcinoma transcript-1 (ICT1) was consis-
tently associated with immunoprecipitation (IP), but it was
neither known to be mitochondrial nor have an experimen-
tally verified function, although it is predicted to be a member
of the prokaryote/mitochondrial release factor family (uni-
prot Q14197). This family is intriguing. We have recently
been able to show that of the four family members,
only mtRF1a is necessary and sufficient to terminate the
translation of all 13 mitochondrially encoded polypeptides
(Soleimanpour-Lichaei et al, 2007; Temperley et al, 2010).
What, therefore, is the function, if any, of the three remaining
family members? We report here that a second member of
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this family, ICT1, is a component of the 39S mt-LSU. It has
retained its ribosome-dependent peptidyl-tRNA hydrolase
(PTH) activity that is essential for cell viability.
Furthermore, this ribosome-dependent PTH activity is
codon-non-specific. We speculate that this ribosome-asso-
ciated activity may be involved in the hydrolysis of pepti-
dyl-tRNAs that have been prematurely terminated and thus in
the recycling of stalled mitoribosomes.
Results
ICT1 is an essential mitochondrial protein
To determine the subcellular location of ICT1, western blot
analysis was performed using cell lysate and enriched mito-
chondria. As shown in Figure 1A, a 3- to 5-fold enrichment
was seen for the mitochondrial matrix protein mtRF1a along
with concomitant increase in ICT1. Crucially, ICT1 was
resistant to addition of proteinase-K to intact mitochondria,
but was lost on solubilisation of the organelle. To assess
whether ICT1 is processed on import into mitochondria, full-
length ICT1 (FL) or a truncated form lacking the N-terminal
29 residues (D29) were prepared. Both proteins were ex-
pressed in Escherichia coli as N-terminal glutathione-S-trans-
ferase (GST)-fusion proteins before cleavage and purification
as detailed under Materials and methods. Migration of en-
dogenous ICT1 in comparison with recombinant proteins
(FL/D29) is consistent with cleavage on mitochondrial im-
port, with the loss of B30 residues.
To assess whether ICT1 serves an essential function in
mitochondria, siRNAs were designed to target the transcript.
Two siRNAs were highly efficient in depleting ICT1 from cells
(Figure 1B), causing a morphological alteration and a reduc-
Figure 1 ICT1 is an essential protein necessary for mitochondrial protein synthesis. (A) Human ICT1 is a mitochondrial protein. Cell lysate (CL
50mg, lanes 1, 5) or mitochondria (10mg, lanes 2–4, 6–8) were isolated from HeLa and HEK293T cells and subjected to western blot analysis
either immediately (lanes 1, 2; 5, 6) or after treatment with proteinase-K (lanes 3, 7). Mitochondria were lysed with Triton X-100 to confirm the
sensitivity of marker proteins to the protease (lanes 4, 8). Mitochondrial release factor-1a (mtRF1a) was used as a mitochondrial matrix marker
and ribosomal protein-S6 (S6-RP) as a cytosolic marker. Purified FL (lane 9) and an ICT1 deleted of N-terminal 29 residues (D29, lane 10) are
shown in comparison with the endogenous protein. (B–E) Depletion of ICT1 inhibits cell growth, impairs mitochondrial protein synthesis and
decreases mitochondrial respiratory chain complexes. HeLa cells in standard glucose media were transfected with either of two siRNAs directed
to ICT1 transcript (si-ICT1A or B) or a non-targeting control (si-NT), and cell numbers were counted at 3-day intervals. Standard errors were
derived from three independent experiments (C). Cell lysates were isolated from non-targeting and ICT1-depleted cells (3 days) and subjected
to western blotting for ICT1 (B) and various markers (D). The relative levels for the MRP MRPL3 and respiratory components NDUFB8 or COX2
were quantified (lower panel) with standard errors derived from three independent repeats. (E) After 3-day siRNA-mediated depletion, cells
were subjected to metabolic labelling of mitochondrial proteins for 15min after inhibition of cytosolic protein synthesis. Aliquots (50 mg) were
separated by 15% SDS–PAGE and exposed to a PhosphorImager. Proteins are identified by comparison against those reported by Chomyn
(1996). A section of the gel stained with Coomassie blue (CBB) following exposure is shown to indicate even loading of cell lysate.
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tion in cell number even when grown on standard, mainly
glycolytic media (Figure 1C). To confirm that effects were
specific and not off-target, cells lacking mtDNA (rho0 cells)
were also transfected with ICT1-specific siRNA and control
siRNAs. The rationale being, as rho0 cells lack mitochondrial
gene expression and are still able to grow on glucose media
supplemented with uridine and pyruvate, depletion of any
protein involved solely in mitochondrial gene expression
should have minimal effect. Accordingly, siRNA-mediated
depletion of b-actin or HSP70 severely compromised the
growth of rho0 cells, whereas growth was unaffected by
depletion of ICT1 or the mitochondrial translation factor
mtEF-Tu (Supplementary Figure S1). These data are
strongly indicative that ICT1 functions in mitochondrial
gene expression.
After only 3 days of ICT1 depletion, a decrease in the
markers of the highly stable mitochondrial respiratory chain
complex-I (NDUFB8) and IV (COX2) was confirmed by
western blotting of HeLa lysates (Figure 1D). Interestingly,
a similar decrease was also noted for the MRP MRPL3,
indicating that levels of mitoribosome and possibly rates of
mitochondrial protein synthesis may be compromised.
Therefore, de novo synthesis of mitochondrial translation
products was assessed by in vivo metabolic labelling.
Figure 1E shows that in the ICT1-depleted cells 35S-met
incorporation is indeed reduced.
ICT1 is a member of the large mitoribosomal subunit
Why does loss of ICT1 lead to reduction in mitochondrial
protein synthesis? To investigate this question and to deter-
mine what components of the mitochondrial matrix asso-
ciated with ICT1, a FLAG-tagged ICT1 was inducibly
expressed in human HEK293T cells, facilitating IP. As
shown in Figure 2A, silver staining uncovered a large number
of proteins, similar to a previous profile where tagged mtRRF
had immunoprecipitated the mitoribosome and associated
proteins (Rorbach et al, 2008). Western blot analysis
(Figure 2B) confirmed the presence of numerous MRPs and
the predicted trace amounts of mtRRF. From proteomic data
of the complete eluate, more than 200 mitochondrial proteins
were identified (Supplementary Table S1), the MRPs being
the most abundant (Supplementary Table S2); consistent with
ICT1 interacting with entire mitoribosomes. As a second
method to determine whether ICT1 was a component of the
mitoribosome, complexes from untransfected cells were se-
parated by isokinetic sucrose density gradients and fractions
were subjected to blotting (Figure 2C). ICT1 co-sediments
with MRPL3 and MRPL12, both components of the 39S mt-
LSU. As has been found in other reports (Nolden et al, 2005;
Williams et al, 2005), the mitochondrial monosome is not
easily identified in cell or mitochondrial lysates by western
blot after density-gradient centrifugation. This was also
evidenced here by the lack of detectable small subunit marker
DAP3 in the more dense fractions (Figure 2C, fractions 7–10).
Therefore, to resolve this issue, we pre-concentrated samples
by first immunoprecipitating mt-LSU and monosomes from
mitochondrial lysates using FLAG-ICT1 and subjected the
entire eluate to an identical gradient centrifugation.
Fractions were then assessed by silver staining and western
blotting. A similar distribution profile is still seen for ICT1
and MRPL3 (excluding free ICT1 caused by overexpression)
(Figure 2D). Crucially, however, DAP3 is now visible in
fractions 7–9, defining the monosomal fractions. Therefore,
ICT1 behaves as an integral member of the 39S mt-LSU and a
component of the intact 55S monosome.
Further support for ICT1 being an integral component of
the 39S mt-LSU, was obtained from ICT1-depleted HeLa cells.
Lysate was subjected to a similar isokinetic gradient, showing
that the mt-LSU marker MRPL3, although present, was
shifted into less dense fractions as compared with that in
cells treated with non-targeting control siRNA (si-NT;
Figure 2E). By contrast, the profile of the 28S mt-SSU protein
DAP3 was unchanged, implying that only assembly of the mt-
LSU and not the mt-SSU is affected on ICT1 depletion.
To confirm that the decrease in mt-LSU assembly observed
in ICT1-depleted cells caused a concomitant decrease in the
level of intact monosome, we used a cell line that expresses a
FLAG-tagged component of the mt-SSU, MRPS27, that was able
to IP both mt-SSU and entire monosome. After 3 days of ICT1
depletion and MRPS27-FLAG induction, FLAG-IP was per-
formed and eluates were blotted (Figure 2F). Levels of DAP3
were unaffected by ICT1 depletion. However, anti-MRPL3 and
MRPL12 antibodies showed a 60% reduction of each of these
proteins in the ICT1-depleted cells, consistent with a decrease
in the monosome formation, presumably due to decreased mt-
LSU assembly. This was also consistent with the decreased 35S
metabolic labelling of mitochondrial proteins as shown in
Figure 1E. Finally, to show that mitoribosomal association of
ICT1 was not simply mediated by the FLAG tag, similar
isokinetic gradients were used to separate the immunoprecipi-
tated eluate from cells expressing MRPL20-FLAG. When
correctly assembled, this FLAG-tagged protein was able to IP
mt-LSU, assembly intermediates and intact monosome. As
show in Figure 2G, ICT1 was clearly associated with mt-LSU
and monosome. These data confirm that ICT1 is an important
component of the complete monosome.
ICT1 is a ribosome-bound, codon-independent PTH
ICT1 is an integral component of the mitoribosome, but on
the basis of homology it is predicted to be a ribosome-
dependent PTH/translation release factor. This is surprising,
as to our knowledge, no other PTH has been shown to be an
integral ribosomal component. There are now four proteins
classified as members of the mitochondrial release factor
family, namely mtRF1a, mtRF1, ICT1 and another unchar-
acterised protein C12orf65 (Figure 3B). Curiously, both ICT1
and C12orf 65 have lost the two domains involved in codon
recognition (a5 and PXT/SPF domain), potentially resulting
in the dangerous situation of release factors that lack codon
specificity. However, none of our previous IPs identified
C12orf65 as a co-precipitant with mitoribosome components
(data not shown). To determine whether ICT1 could promote
hydrolysis of the ester bond between the growing peptide and
the P-site tRNA, we used a well-established assay using
isolated E. coli ribosomes, tritiated fmet-tRNAMet, synthetic
codons and purified ICT1 (Caskey et al, 1971; Tate and
Caskey, 1990; Soleimanpour-Lichaei et al, 2007). In compar-
ison to the exquisite codon selectivity of mtRF1a, ICT1
promiscuously promoted the release of formylmethionine
from its P-site tRNA irrespective of the codon sequence
used to programme the assay and indeed even in the absence
of codons in the A-site (Figure 3C). To determine whether
ICT1 possessed a direct ribosome-independent PTH activity,
or whether it functioned specifically to promote ribosome-
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dependent hydrolysis, purified ICT1 was incubated with
f[3H]met tRNAmet in the absence of ribosomes before extrac-
tion and estimation of standard release factor activity.
No significant increase in counts was noted over background,
confirming that no significant hydrolysis of the substrate
occurred in the absence of the ribosome (Figure 3C).
Figure 2 ICT1 is an integral component of the mitoribosome. (A, B) FLAG-tagged ICT1 immunoprecipitates mitoribosomes. HEK293T cells
expressing FLAG-tagged ICT1 or mitochondrially localised luciferase (mtLuc-FLAG) were induced for 3 days; mitochondria were isolated, lysed
and subjected to IP as detailed. The eluate and mitochondrial lysate before IP (IP-input) were separated by 15% SDS–PAGE and visualised by
silver staining. * designates the FLAG protein. (B) Aliquots of the eluates were also subjected to western blot analysis with the indicated
antibodies: MRPL3, MRPL12, MRPS6 and DAP3 as mitoribosomal markers; mtRRF, mitoribosome recycling factor; SDH, 70-kDa component of
complex-II. (C) ICT1 co-sediments with the large mitoribosomal subunit. HeLa cells were lysed (600 mg), separated through a 10–30% sucrose
gradient and fractionated as detailed (HeLa and HEK293T lysates gave identical separations). Components of the 39S mt-LSU (MRPL3,
MRPL12) and 28S mt-SSU (DAP3) mitoribosomal subunits were visualised by western blotting. On immediate lysis, mtRRF is used as a matrix-
soluble marker. (D) ICT1 also co-sediments with the intact monosome. Mitochondria (3mg) of ICT1-FLAG-expressing HEK293T cells were
subjected to FLAG IP; the entire eluate was separated by isokinetic density gradients and fractions were blotted as detailed above or visualised
by silver staining (lower panel). Mitochondrial SSU (DAP3) and mt-LSU (MRPL3) MRPs are visualised. The approximate indicators for 28S mt-
SSU, 39S mt-LSU and 55S monosome are shown and were determined as described under Materials and methods. (E) ICT1 is an integral
member of 39S mt-LSU. Cell lysates (600 mg) from ICT1-depleted (si-ICT1B) or non-targeted control cells (si-NT) were separated by isokinetic
gradients and proteins were visualised in the fractions by western blotting as described. Sedimentation markers were identified as above.
(F) Loss of ICT1 causes depletion of the monosome. Cells expressing MRPS27-FLAG were treated with si-NT or si-ICT1B, after which IP was
performed. To assess monosome formation, levels of MRPL3 and MRPL12 were quantified by western blotting of three individual experiments
(right panel; MRPL3 P¼ 0.001, MRPL12 Po0.001, MRPS27 P¼ 0.3). (G) ICT1’s association with mitoribosomes is not FLAG-dependent.
Mitochondria from cells expressing MRPL20-FLAG were subjected to FLAG IP and the eluate was analysed by western blotting after isokinetic
density gradients as described in panel D.
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A mutation of the GGQ domain of ICT1 causes loss
of cell viability
ICT1 is an essential MRP with a ribosome-dependent yet
codon-independent PTH activity, in vitro. Is it possible that
ICT1 needs to maintain this activity when it is assembled into
the mitoribosome, in vivo?
PTH activity of release factors is mediated by the domain
containing the tripeptide motif GGQ (Frolova et al, 1999;
Figure 3A and B). It has been shown that mutations in
either of the two glycine residues completely abolishes in
vitro PTH activity while retaining the structural integrity of
the protein (Frolova et al, 1999). To determine whether the
GGQ domain is critical for ICT1’s function, we reproduced
two of these GGQ mutants by site-directed mutagenesis.
First, recombinant ICT1GSQ and ICT1AGQ were purified,
monodispersion was confirmed by dynamic light scattering,
and then they were subjected to the release assay described
above (Figure 4A). Each retained B1% of peptide-
release activity (GSQ 1.1%, AGQ 0.8% residual activity).
Having confirmed the requirement of the GGQ domain for
the PTH activity of ICT1, it was then possible to assess the
importance of the PTH activity in vivo. If PTH activity is
crucial then replacement of wild-type ICT1 with ICT1GSQ
would be predicted to compromise mitochondrial gene ex-
pression, leading to reduced growth on galactose.
Consequently, an HEK293T cell line was engineered to
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express a FLAG-tagged version of ICT1GSQ and compared
with the wild-type ICT1-FLAG expressor. On induction,
the ICT1 mutant was incorporated into mitoribosomes,
which were assembled at levels similar to that in the
wild-type transfected control (Figure 4B and C), but induction
resulted in a substantial overexpression of ICT1GSQ such
that the majority of the protein remained free and not
mitoribosome-bound (Figure 4C). A similar overexpression
was also noted on induction of wild-type ICT1-FLAG
(Figure 4C, upper panels), which in itself produced a mild
growth phenotype. To reduce the levels of the overexpressed
protein to that of the endogenous untransfected controls and
concomitantly deplete the endogenous ICT1, serial dilutions
of si-ICT1B were used. A concentration of siRNA was
achieved that resulted in levels of FLAG-tagged ICT1 equiva-
lent to that of the untransfected controls (10 nM; Supple-
mentary Figure S2). Using this strategy, growth rates of these
various cell lines were compared, uncovering a slower dou-
bling time in the ICT1GSQ mutant, confirming that ICT1
requires a functional GGQ domain to maintain cell viability
(Figure 4D, 3 cf. 4).
Discussion
Following stringent purification methods, isolation of bovine
mt-SSU, mt-LSU and the 55S monosome has allowed char-
acterisation of many constituents and a low-resolution struc-
ture (Sharma et al, 2003). These data are in agreement that
the mammalian mitoribosome differs substantially from
other ribosomes that have been characterised. In particular,
the 30:70 (w:w) protein-to-RNA ratio is reversed, with only
one reduced rRNA component for each subunit and an
increased number of protein factors, as determined by initial
LCMS, resulting in a larger, more porous structure (O’Brien,
2002). Were some MRPs missed in this original screen? Our
data indicates that ICT1 is indeed one such protein.
ICT1 is classified bioinformatically as one of four members
of the prokaryotic/mitochondrial release factor family. It is
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now known that all 13 mitochondrial encoded polypeptides
terminate translation with the aid of mtRF1a (Soleimanpour-
Lichaei et al, 2007; Temperley et al, 2010). A third member,
mtRF1, has yet to be shown to have release-factor activity,
but, similar to ICT1 and mtRF1a, is an essential mitochon-
drial protein. The final member, C12orf65 currently has an
unknown function, although with a mitochondrial location
(unpublished observation). ICT1 and C12orf65 are signifi-
cantly smaller than the RF1 and RF2 types of class-I bacterial
release factors. Alignments highlight that this loss occurs in
three main regions: the N-terminus and the two sections
(tripeptide motif and the tip of the a-5 helix) that come into
close contact with the mRNA in the ribosomal A-site and
determine the STOP codon specificity (Figure 3). Lack of
these domains is consistent with the loss of codon specificity
noted for ICT1 in this study. By contrast, there is striking
sequence conservation of the GGQ motif. By superimposing
the available structure of the mouse ICT1 on RF1
(Thermotoga maritima) and RF2 (Thermus thermophilus),
it is clear that in all three proteins the GGQ motif reside in
a flexible loop (Figure 3A). Furthermore, although there is
reduced sequence identity in this domain, the structural
features surrounding this motif are highly conserved and
important in positioning the GGQ at the surface of the RF
(Frolova et al, 1999). This suggests that maintaining the way
in which the GGQ motif is presented to the substrate is
important. Curiously, ICT1 contains a stretch of 25 residues
that has no sequence similarity to C12orf65 or the other RFs
(Figure 3B, bold, italics). In the structural superimpositions,
this feature can also be distinguished, primarily in the
unmatched horizontal helix in ICT1. As this feature is lacking
in release factors that interact transiently with the ribosome
and also from C12orf65 that does not IP with the mitoribo-
some, it is possible that this feature is involved in the
integration of ICT1 into the mt-LSU.
What could be the function of a ribosome-bound, codon-
independent PTH and how could its capacity for indiscrimi-
nate peptide release be controlled and positively harnessed?
There are several possibilities. First, if mitoribosomes initiate
translation on 30 truncated or mutated mt-mRNA that lack
termination codons, the terminus of the mRNA will even-
tually reach the P-site and be retained by the anchoring
peptidyl-tRNA but will leave an A-site devoid of mRNA or
release factors to trigger recycling. In the absence of a
mitochondrial analogue to the bacterial tmRNA system that
rescues stalled ribosomes (Keiler et al, 1996), PTH activity
will be needed to liberate the peptide from the peptidyl-tRNA,
forming a substrate that can be recycled. A similar activity
would be necessary to help recycle mitoribosomes that have
prematurely stalled. Alternatively, many genetic studies
have highlighted the necessity of salvaging tRNA species
from prematurely released peptidyl-tRNAs generated
through abortive elongation events during protein synthesis,
a function normally provided by a freely soluble PTH (re-
viewed by Das and Varshney, 2006). To date no human
mitochondrial protein is known to show this activity
(although candidates exist). Our data are consistent with
mammalian mitoribosomes streamlining this process by in-
corporation of a codon-independent PTH activity that can
recognise and hydrolyse peptidyl-tRNAs caught during their
premature release from the mitoribosome (or even from the
mt-LSU if the stalled ribosome dissociates, as has been
suggested for E. coli ribosomes by Varshney and co-workers
(Singh et al, 2008)).
Cryo-EM data of mammalian mitoribosomes uncovers a
feature absent in the bacterial ribosomes. This is a surface
cavity in the mt-LSU near the exit tunnel, described as the
polypeptide-accessible site (PAS) that prematurely exposes
the nascent peptide to the solvent (Sharma et al, 2003;
Figure 5A). It is created by loss of rRNA regions and proteins
orthologous to bacterial components (O’Brien, 2002).
Integration of ICT1 at this mitoribosomal site could allow
access to peptidyl-tRNAs caught on release from the mitor-
ibosome after aborted elongation (Figure 5C). Ribosomes use
substrate-induced fit mechanisms to promote conformation
changes that facilitate either peptide bond formation or
hydrolysis (Schmeing et al, 2005). Premature release of a
peptidyl-tRNA may cause ribosomal distortion, resulting in
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GGQ domain
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Figure 5 A schematic representation of the putative position and
function of ICT1 in the human mitochondrial ribosome. (A) A
simplified cartoon of the 55S mitochondrial ribosome indicating
the polypeptide exit tunnel and site (PES) and the PAS in the large
subunit as defined by Sharma et al (2003). No orthologues of the
proteins that would occupy the PAS have been found in mammalian
mitochondria, and we postulate that is where ICT1 is positioned
with the GGQ domain inserted deep into the pocket. Sites for the
aminoacyl (A) and peptidyl (P) tRNAs are shown. The mt-mRNA is
depicted between the large and small mt-ribosomal subunits.
(B) Under conditions of normal termination, the ester bond of the
peptidyl-tRNA is positioned close to the peptidyl-transferase centre
(PTC); the release factor, mtRF1a, enters through the A-site, recog-
nising the stop codon (UAA) and aligning the GGQ domain at the
PTC to promote hydrolysis of the ester bond and release of the
nascent peptide. (C) Where abortive elongation occurs, the pepti-
dyl-tRNA may drop away from the P-site towards the PES, aligning
the ester bond close to the GGQ domain of ICT1, promoting
cleavage of the tRNA, which allows both mt-tRNA and truncated
peptide to be released from the mitochondrial monosome (or
potentially from dissociated 39S mt-LSU).
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the juxtaposition of the GGQ motif and peptidyl-tRNA, pro-
moting ester bond hydrolysis in a codon-independent man-
ner. Crucially, this would release the tRNA for recharging.
Clearly, to support any of these hypotheses, it would be of
enormous benefit to generate high-resolution structural data
to identify exactly where in the mitoribosome ICT1 is found.
To date, there are only very limited structural data concerning
the mammalian mitoribosome and producing such structural
data is beyond the scope of this paper. Further experiments
will be necessary to elucidate the exact role of this PTH
activity; however, it is interesting to note that ICT1 is mito-
chondrial, has become incorporated into the mitoribosome,
lost all stop codon specificity, but has acquired another
function of equal importance to mitochondrial translation.
Contrastingly, mtRF1a has retained its RF activity. It is
tempting to speculate on what diverging fates may also
have befallen the other two members of this family.
Materials and methods
Cell culture
Human HeLa cells were cultured (371C, humidified 5% CO2) in
Eagle’s MEM (Sigma) supplemented with 10% (v/v) foetal calf
serum (FCS), 1 non-essential amino acids (NEAA) and 2mM
L-glutamine. 143B.206 rho0 osteosarcoma cells (provided by R
Wiesner, University of Koeln) were propagated in Dulbecco’s
modified Eagle’s medium supplemented with 10% (v/v) FCS,
50mg/ml uridine and 1 NEAA. Flp-InT-Rex-293 cells (HEK293T;
Invitrogen) were grown in identical media supplemented with
10 mg/ml BlasticidinS and 100mg/ml Zeocin (Invitrogen). Post-
transfection selection was performed with HygromycinB (100 mg/
ml). For growth on respiratory substrates, the medium contained
glucose-free DMEM (Gibco), 0.9mg/ml galactose, 1mM sodium
pyruvate, 10% (v/v) FCS, NEAA and 2mM L-glutamine. For growth
curve analyses, the galactose medium included 50mg/ml uridine.
Subcellular localisation
Human mitochondria or cell lysates were prepared in a homo-
genisation buffer (10mM Tris–HCl (pH 7.4), 0.6M mannitol, 1mM
EGTA) by differential centrifugation. Aliquots of mitochondria were
treated with proteinase-K (4mg/100mg protein) for 30min at 41C
and either lysed (1% final v/v Triton X-100) or treated with 1mM
PMSF before separation through 15% PAG and transfer to a PVDF
membrane. Western blots were performed and developed as
described by Soleimanpour-Lichaei et al (2007).
siRNA constructs and transfection
Three sequences targeting ICT1 were tested for efficiency of protein
depletion. The nucleotide positions are relative to the reference
sequence NM_001545.1; sense strands were as follows:
si-ICT1A 50 CUAGAUCGCUUGACAAUAU dTdT 30 (nt 222–240);
si-ICT1B 50 GCCGCUAUCAGUUCCGGAA dTdT 30 (nt 421–439)
and
si-ICT1C 50GGGUCCCGAAUGGUGCAAA dTdT 30 (nt 181–199).
Experiments were performed with si-ICT1B unless otherwise
specified. si-ICT1C was found to be ineffective. Transfections were
performed with 20% confluent HeLa cells using Oligofectamine
(Invitrogen) in Optimem-I medium (Gibco) with 0.2mM siRNA.
Reverse transfections were performed as described by Ovcharenko
et al (2005) using approximately 12 000 HEK293Tcell per cm2 using
Lipofectamine RNAiMAX (Invitrogen) in Optimem-I medium
(10–33 nM siRNA). Custom and control non-targeting (NT; ref.:
OR-0030-neg05) duplex siRNAs were purchased pre-annealed from
Eurogentec.
In vivo mitochondrial protein synthesis
Mitochondrial protein synthesis in cultured cells was performed as
described by Chomyn (1996) after addition of emetine and pulsed
with [35S]-methionine for 15min. Aliquots (50 mg) of total cell
protein were separated by 15% (w/v) SDS–PAGE. The gels were
exposed to PhosphorImage cassettes and visualised using the
ImageQuant software.
Production of FLAG- and GST-fusion constructs, transfection,
expression and purification
The original human ICT1 clone was obtained from MGC
(MGC:21251; accession no. BC015335) and encodes the only
isoform to be described. All constructs were prepared by PCR
using the MGC clone as template. Constructs to facilitate inducible
expression of C-terminal FLAG-tagged ICT1 were prepared by
generating an amplicon from nt 2 to 620 using the following
primers: 50-CTTTCTTAAGCTTCCACCATGGCGGCCACCAGGTG-30
and 50-CTCTCCGATATCCTACTTATCGTCGTCATCCTTGTAATCGTCC
ATGTCGACCCTC-30. The amplicon and pcDNA5/FRT/TO (Invitro-
gen) were digested with HindIII/EcoRV and ligated. C-terminal
FLAG-tagged MRPS27 and MRPL20 were constructed by PCR
amplification from MGC clones 6009616 and 3542715 (accession
nos. BC064902 and BC009515), respectively, using primers 50-CTTT
CTTGGATCCCCACCATGGCTGCCTCCATAGTGCG-30 and 50-CTCTCT
CTCGAGCTACTTATCGTCGTCATCCTTGTAATCGGCAGATGCCTTTGC
TGCTT-30 (MRPS27 Forward and Reverse) or 5-TACTATAAGCTTAC
CATGGTCTTCCTCACCG-3 and 5-ATACTACTCGAGCTACTTATCGTC
GTCATCCTTGTAATCGTGGTACTGCACCACTC-3 (MRPL20 Forward
and Reverse). The amplicons were digested with BamHI/XhoI or
HindIII/XhoI, respectively, and ligated into similarly digested
pcDNA5/FRT/TO. The GST-fusion constructs were made of the FL
or N-terminal-deleted (D29) ICT1. These were generated by
amplifying nt 2 or 90–623, respectively. The forward primers
incorporated a BamHI site (FL Forward 50-CTTTCTTGGATCCAT
GGCGGCCACCAGGTG-30; D29 Forward 50-CTTTCTTGGATCCCTG
CACAAGCAGAAAGACG-30) and the same reverse primer was used
for both amplification reactions (Reverse 50-CTCTCCCTCGAGT
CAGTCCATGTCGACCCTC-30 containing an XhoI site). The ampli-
cons and vectors were digested to allow in-frame downstream
fusion of ICT1-GST in pGEX-6P-1 (GE Healthcare). The constructs
derived from pGEX-6P-1 or pcDNA5/FRT/TO were used for
transfection of E. coli Rosetta pLysS (Merck Biosciences) or
HEK293T cells, respectively. Bacteria were induced, and protein
was purified and cleaved from GST using PreScission Protease
exactly as previously described for mtRRF (Rorbach et al, 2008).
Bacterial expression of both FL GST-ICT1-fusion protein and D29
was deleterious to growth, but was not lethal. Human HEK293T
cells were transfected atB50% confluence with the vectors pOG44
and pcDNA5/FRT/TO containing sequences of the genes to be
expressed (FLAG-tagged ICT1, mtLuc and derivatives) as previously
described (Soleimanpour-Lichaei et al, 2007).
Dynamic light scattering
Dynamic light scattering measurements were performed using a
commercial Zetasizer 1600 (Malvern Instruments) equipped with a
He–Ne laser (633 nm, 5mW). Aliquots (20ml) of protein samples
(concentrations of 0.1–1mg/ml) were pipetted into low-volume
glass cuvettes and equilibrated for 3min in the apparatus before
measurement. All samples were measured a minimum of five times
at 251C for 70 s.
Affinity purification and elution of FLAG peptides
Mitochondria were isolated from HEK293T cells expressing FLAG
derivatives and treated with DNase-I (0.5U/mg mitochondria;
15min RT) and proteinase-K (5mg/mg mitochondria; 30min 41C)
followed by 1mM PMSF inhibition. The pelleted mitochondria were
washed in a homogenisation buffer, treated with digitonin to
remove the outer membrane (400mg/mg mitochondria), washed
and resuspended in a lysis buffer (50mM Tris–HCl (pH 7.4),
150mM NaCl, 10mM MgCl2, 1mM EDTA, 1% (v/v) TX-100, 1
protease inhibitor cocktail (Roche), 1mM PMSF). IP was performed
using an anti-FLAG M2-agarose affinity gel following manufac-
turer’s recommendations (Sigma Aldrich, St Louis, MO, USA).
Elution was performed using 5 mg of 3 FLAG peptide per 100ml of
an elution buffer.
LC MS/MS analysis of negative control and ICT1 IP
The immunopurification of ICT1 and negative control (IP eluate
from the lysate of untransfected HEK293T cells subjected to the
identical IP protocol with anti-FLAG M2-agarose) were separated
using SDS–PAGE. Individual gel lanes were cut into three bands and
were in-gel digested as described elsewhere (Wilm et al, 1996). The
resulting peptide solutions were desalted and concentrated offline
using STAGE tips (Rappsilber et al, 2003). Measurements were
performed using an Agilent 1100 nanoflow system connected
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through a nano-electrospray ion source to a 7T linear ion-trap
Fourier transform ion cyclotron resonance mass spectrometer (LTQ
FT ULTRA; Thermo Scientific). Peptide separations were performed
using a 15-cm fused silica emitter (New Objective, PicoTip Emitter;
tip: 8±1mm, ID: 100mm, FS360-100-8-N-5-C15) packed with
reversed-phase ReproSil-Pur C18AQ 3-mm resin purchased from
Dr Maisch GmbH. Samples were loaded directly onto the analytical
column at a flow of 600nl/min eluent-A (3% acetonitrile, 0.5%
acetic acid). Bound peptides were eluted from the column at a rate
of 300nl/min using an LC gradient of 10–40% eluent-B (80% v/v
acetonitrile, 0.5% acetic acid) in 60min, followed by a steep
gradient of 40–100% eluent-B in 5min. The mass spectrometer was
programmed to select the top four most abundant ions from each
survey scan in the ICR cell for subsequent fragmentation analysis
using collision-induced dissociation (CID) in the linear ion trap.
Only double and triple charged ions were selected for CID analysis,
and dynamic exclusion with early expiration was enabled to prevent
re-selection of previously fragmented ions.
MRP identification and data analysis
Precursor and fragment ions were extracted from raw data files using
ExtractMSn (Thermo Scientific). Individual LC MS/MS data files of all
three gel slices were combined for each sample before database
search. Peptides were identified by automated database searches
using Mascot (Matrix Science Mascot version 2.2) against the Refseq
database (release 29) and a Refseq reverse database for automated
validation using false-discovery rate calculations. Database searches
were performed with a 20-p.p.m. precursor ion tolerance and 0.8-Da
tolerance for MS/MS fragment ions using the following specifications:
tryptic cleavage allowing one missed cleavage, carbamidomethylation
(C) as fixed modification, and allowing deamidation (NQ) and
oxidation (M) as variable modifications. Subsequent peptide identi-
fications were blasted against the Refseq database and validated by
false-discovery rate calculation using the PROVALT software (Weath-
erly et al, 2005). PROVALTwas set to calculate peptide score cut-offs to
achieve a calculated o1% false-discovery rate. Protein abundances
were calculated as exponentially modified Protein Abundance Index
(emPAI) values according to Ishihama et al (2005). MRPs were
marked as enriched if (i) they were identified with at least three
unique peptides and (ii) when emPAI values were at least twofold
higher in the ICT1 IP sample as compared with that in the negative
control. The table represents only identified human MRPs that appear
in the Refseq database.
Isokinetic sucrose-gradient analysis of mitochondrial
ribosomes
Total cell lysates (0.5–0.7mg in lysis buffer) or eluted immunopre-
cipitates were loaded on a linear sucrose gradient (1ml 10–30%
(v/v)) along with 50mM Tris–HCl (pH 7.2), 10mM Mg(OAc)2,
40mM NH4Cl, 0.1M KCl, 1mM PMSF, and 50mg/ml chloramphe-
nicol, and centrifuged for 2 h 15min at 100 000 g at 41C. Fractions
(100ml) were collected and 10-ml aliquots were analysed directly by
western blotting or silver staining as follows: PAG were fixed in
50% methanol for 1 h, followed by 15-min incubation in staining
solution (0.8% (w/v) AgNO3; 1.4% (v/v) NH4OH; 0.075% (w/v)
NaOH), three washes of 5min each in nanopure dH2O, and then
developed in 0.055% (v/v) formaldehyde/0.005% (w/v) citric acid
and fixed in 45% methanol/10% acetic acid.
Northern blot analysis for mitoribosomal subunit markers
in gradient gel fractions
To identify the 28S mt-SSU and 39S mt-LSU in gradient fractions, the
12S and 16S mt-rRNA were visualised by northern blotting. RNA
was prepared by phenol extraction from half of each gradient
fraction. Northern blots were performed as described by Chrza-
nowska-Lightowlers et al (1994). Briefly, aliquots of RNA (5mg)
were electrophoresed through 1.2% agarose under denaturing
conditions and transferred to GenescreenPlus membrane (NEN
duPont) following the manufacturer’s protocol. Probes were
generated using random hexamers on PCR-generated templates
corresponding to the internal regions of the 12S and 16S mt-rRNA.
An estimate of 55S monosome was made from the position of the
cytosolic 28S rRNA (representing the 60S cytosolic LSU) visualised
on ethidium bromide staining of the agarose gel.
Mutagenesis of ICT1
Mutations in the GGQ tripeptide were introduced into the bacterial
(AGQ, GSQ) and human (GSQ) ICT1 expression constructs
following the QuikChange II site-directed mutagenesis protocol
(Stratagene). The following primers and their complements were
used; base changes from wild type are underlined: AGQ, 50-GTA
GTGGTCCTGCGGGGCAGAATG-30; GSQ, 50-GTGGTCCTGGGTCGCA
GAATGTGAAC-30.
In vitro release-factor assay
E. coli ribosomes were purified and assays were performed essentially
as described by Tate and Caskey (1990) with modifications as detailed
in reference Soleimanpour-Lichaei et al (2007). Briefly, an f[3H]met-
tRNAmet substrate was made by combining 3.8 nmol L-[methyl-3H]-
methionine (GE Healthcare) and cold methionine up to a concentra-
tion of 21.8nmol, 3.5mM leucovorin (Sigma) as the formyl donor,
20mM amino acids (Promega), 0.3mg N-formylmethionine-specific
tRNA (Sigma), 1.2mM ATP, 1mM DTT, 10mM MgCl2, in cacodylate
buffer (100mM, pH 6.8), and incubating for 30min at 371C. The
ribosomal substrate (amounts given are per 50ml of assay) was
prepared by incubation of 70S ribosomes (5 pmol) with AUG
(250pmol) and f[3H]met-tRNAmet (2.5pmol) in 20mM Tris–HCl (pH
7.4), 10mM Mg(OAc)2 and 150mM NH4Cl at 301C for 20min. This
‘activated’ ribosomal substrate was stored on ice before interrogation
with release factors for activities with selected codons. Reactions that
lacked the 70S were otherwise identical.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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